Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Aurinia Reports Third Quarter 2016 Financial Results and Operational Highlights
-
InVivo Therapeutics Reports 2016 Third Quarter Financial Results and Business Update
-
Cantor Fitzgerald Starts AngioDynamics (ANGO) at Buy
-
Cantor Fitzgerald Adds Three Senior Fixed Income Salespeople
-
Cantor Fitzgerald Reiterates Sell on bluebird bio (BLUE) Following ASH Abstracts
-
Notable Analyst Rating Changes 11/2: (SQ) (NUE) (SU) Upgraded; (ILMN) (H) (BKD) Downgraded
-
Alignvest Acquisition Corporation and Trilogy International Partners LLC Announce Proposed Business Combination
-
Cantor Fitzgerald Starts Bellicum Pharmaceuticals (BLCM) at Buy
-
Abeona Therapeutics Inc. Announces Closing of its Underwritten Offering of Common Stock
-
Signal Genetics (SGNL) to Merge with Miragen Therapeutics
-
Orchid Island Capital Announces Third Quarter 2016 Results
-
Theravance Biopharma (TBPH) Prices 3.85M Shares, $200M Conv. Notes Offerings
-
Cantor Fitzgerald Starts Cidara Therapeutics (CDTX) at Buy
-
Theravance Biopharma Announces Pricing of Public Offerings of 3,850,000 Ordinary Shares and $200 Million of 3.25% Convertible Senior Notes due 2023
-
Abeona Therapeutics (ABEO) Prices 6M Shares at $7/Share
-
Abeona Therapeutics Announces Pricing of Public Offering of Common Stock
-
Dynavax Secures Committed Financing From Deerfield for $100 Million of Senior Secured Notes
-
Theravance Biopharma (TBPH) Announces $100M Shares, $150M Conv. Stock Offerings
-
Theravance Biopharma Announces Proposed Public Offerings of $100 Million of Ordinary Shares and $150 Million of Convertible Senior Notes
-
Cantor Fitzgerald Defends Corbus Pharmaceuticals (CRBP) Following Short Report
-
Cantor Fitzgerald Upgrades EastGroup Properties (EGP) to Hold
-
Abeona Therapeutics (ABEO) ABO-102 Data is a 'Promising Start' - Cantor Fitzgerald
-
A.M. Best to Host Webinar on What Insurers Should Know about ETFs & Issuers
-
Notable Analyst Rating Changes 10/19: (TWTR) (YUM) (WNR) Upgraded; (FE) (Q) (NCLH) Lower
-
Cantor Fitzgerald Starts GoDaddy Inc (GDDY) at Buy
-
Cantor Fitzgerald Starts Wix.com (WIX) at Buy
-
Cantor Fitzgerald Starts Endurance International Group (EIGI) at Hold
-
Cantor Fitzgerald Starts Web.com, Inc. (WEB) at Hold
-
ELS Reports Third Quarter Results
-
Omeros (OMER): Reiterating $21 PT On Solid Prelim Phase II Data - Cantor Fitzgerald
-
PlacementTracker Publishes Q3 2016 Private Placement Market League Tables
-
Unusual 11 Mid-Day Movers 10/14: (CTRV) (FBMS) (MGT) Higher; (OPTT) (TAYD) (BIOC) Lower
-
Notable Analyst Rating Changes 10/14: (UA) (CAG) (LVLT) Upgraded; (URI) (BLUE) (RDS-A) Downgraded
-
UPDATE: Cantor Fitzgerald Downgrades bluebird bio (BLUE) to Sell
-
First Empire Adds Asset-Backed Securities Trader and Expands Product Lineup
-
Cantor Fitzgerald Downgrades Flex Pharma (FLKS) to Hold
-
Cidara Therapeutics Announces Closing of Public Offering of Common Stock, Including Exercise of Underwriter’s Option to Purchase Additional Shares
-
Orchid Island Capital Announces October 2016 Monthly Dividend and September 30, 2016 RMBS Portfolio Characteristics
-
Amazon's (AMZN) Price Target Raised to $1000 at Cantor Fitzgerald
-
Cantor Fitzgerald Downgrades Chatham Lodging Trust (CLDT) to Hold
-
Cidara Therapeutics (CDTX) Prices 2.48M Common Stock Offering at $10.10/Share
-
Cidara Therapeutics Announces Pricing of Public Offering of Common Stock
-
Cantor Fitzgerald Starts Fiserv (FISV) at Hold
-
Cantor Fitzgerald Starts Fidelity National Information Services (FIS) at Buy
-
Cidara Therapeutics (CDTX) to Offer Common Stock
-
Cidara Therapeutics Announces Commencement of Public Offering of Common Stock
-
Cantor Fitzgerald Starts The Trade Desk (TTD) at Buy
-
Notable 52-Week Highs and Lows 10/5: (ECA) (REN) (CRBP) High; (TEVA) (TTD) Low
-
Unusual 11 Mid-Day Movers 10/5: (CPRX) (CRBP) (UEPS) Higher; (IMMU) (AZZ) (CTSO) Lower
-
Notable Analyst Rating Changes 10/5: (JONE) (PAA) (CMRE) Upgraded; (NCLH) (GNW) (VNR) Downgraded


